Business
Cannara Biotech Inc. to Present at Canaccord Genuity's 6th Annual Cannabis Conference on May 11th and Retains Bristol Capital for Investor Relations Services
Cannara Biotech Inc. to Present at Canaccord Genuity's 6th Annual Cannabis Conference on ...
About this update from Cannara Biotech, Inc.
[{"type":"text","content":"\n \n \n \n Cannara Biotech Inc. to Present at Canaccord Genuity's 6th Annual Cannabis Conference on May 11th and Retains Bristol Capital for Investor Relations Services\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n MONTREAL\n \n \n ,\n \n \n May 4, 2022\n \n \n /CNW/ -\n \n Cannara Biotech Inc.\n \n (\"\n \n Cannara\n \n \" or the \"\n \n Company\n \n \") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega  facilities based in Québec spanning over 1,650,000 sq. ft., today announced the Company's Chief Financial Officer,\n \n Nicholas Sosiak\n \n , will be presenting at Canaccord Genuity's 6\n \n th\n \n Annual Cannabis Conference at\n \n 10:30am\n \n Eastern on\n \n May 11\n \n \n th\n \n , 2022. Mr. Sosiak will present the Company's corporate highlights and also provide an update on the company's second quarter financial results.\n \n \n \n \n \n \n \n \n \n In order to watch the Company's presentation, please register\n \n here\n \n .\n \n \n Mr. Sosiak will also be available for virtual 1x1 meetings during the conference. If you would like to arrange a 1x1 meeting with Mr. Sosiak, please contact your Canaccord Genuity salesperson to schedule.\n \n \n The Company also announced that it has retained Bristol Capital Ltd. (\"Bristol\") a leading investor relations firm servicing Canadian and US microcap and small cap companies across international markets, to provide investor relations and communication services.\n \n \n \n Bristol\n \n has agreed to comply with all applicable securities laws and the policies of the TSX Venture Exchange (the \"TSXV\") in providing the Services.\n \n \n \n Bristol\n \n has been engaged by the Company for an initial period of 12 months (the \"Initial Term\") which shall be renewed automatically for successive one-year periods thereafter, unless terminated in accordance with the provisions of agreement.\n \n Bristol\n \n will be paid a monthly fee of up to\n \n $14,000\n \n , plus applicable tax...